[HTML][HTML] Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence

P Viale, CE Sandrock, P Ramirez, GM Rossolini… - Annals of intensive …, 2023 - Springer
Appropriate antibiotic treatment for critically ill patients with serious Gram-negative infections
in the intensive care unit is crucial to minimize morbidity and mortality. Several new …

[HTML][HTML] Prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: review of the evidence

M Kollef, H Dupont, DE Greenberg, P Viale… - International Journal of …, 2023 - Elsevier
Carbapenem-resistant Acinetobacter baumannii (CRAB) has been classified by the World
Health Organization as being in the critical category of pathogens requiring urgent new …

[HTML][HTML] Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted …

M Mazzitelli, D Gregori, L Sasset, M Trevenzoli… - Microorganisms, 2023 - mdpi.com
Background. A large increase in multi-drug-resistant Acinetobacter baumannii, especially
carbapenem-resistant strains, occurred during the first two years of the COVID-19 pandemic …

Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study

E Rando, SL Cutuli, F Sangiorgi… - JAC-Antimicrobial …, 2023 - academic.oup.com
Background Cefiderocol is a novel β-lactam with activity against carbapenem-resistant
Acinetobacter baumannii (CRAB), but its role in CRAB pulmonary infections is controversial …

[HTML][HTML] Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022

M Coppi, A Antonelli, C Niccolai, A Bartolini… - …, 2022 - eurosurveillance.org
A nosocomial outbreak by cefiderocol (FDC)-resistant NDM-1-producing Klebsiella
pneumoniae (NDM-Kp) occurred in a large tertiary care hospital from August 2021–June …

[HTML][HTML] Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales

RA Bonnin, C Emeraud, AB Jousset, T Naas… - Clinical Microbiology and …, 2022 - Elsevier
Objectives Cefiderocol is a catechol-substituted cephalosporin dedicated to the treatment of
infections caused by multidrug resistant gram-negative rods. Cefiderocol susceptibility …

[HTML][HTML] Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant …

L Devoos, A Biguenet, J Rousselot, M Bour… - Clinical Microbiology …, 2023 - Elsevier
Objectives To evaluate the performance of commercially available tests to determine the
susceptibility of multidrug-resistant (MDR) clinical Pseudomonas aeruginosa strains to …

[HTML][HTML] Phytochemical profiling of Salsola tetragona Delile by LC-HR/MS and investigation of the antioxidant, anti-inflammatory, cytotoxic, antibacterial and anti-SARS …

N Cherrada, AE Chemsa, E Erol, AG Akyildiz… - Saudi Pharmaceutical …, 2023 - Elsevier
This study aimed to investigate the phytochemical composition and biological activity of
Salsola tetragona Delile.(Amaranthaceae), a medicinal plant. The study evaluated the …

Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii …

G Bianco, M Boattini, S Comini, P Gaibani… - European Journal of …, 2024 - Springer
Purpose Cefiderocol susceptibility testing (AST) represents an open challenge for clinical
microbiology. Herein, we evaluated the performance of the UMIC® Cefiderocol broth …

[HTML][HTML] Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol …

K Jeannot, S Gaillot, P Triponney, S Portets, V Pourchet… - Microorganisms, 2023 - mdpi.com
Cefiderocol is a siderophore-conjugated cephalosporin with potent activity against multidrug-
resistant Gram-negative pathogens including Acinetobacter baumannii. The aim of this study …